Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Holders of 5% or more of MIRM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Mirum Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G/A | 14.30%22.7M shares | +3.30 ppfrom 11.00% | Jul 10, 20244 filings | May 14, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 9.70%5.91M shares | −2.10 ppfrom 11.80% | Feb 14, 20259 filings | Aug 13, 2026 | SEC |
| Frazier Life Sciences IX, L.P. | 13D/A | 6.80%4.11M shares | −0.80 ppfrom 7.60% | Aug 16, 20226 filings | Jan 27, 2026 | SEC |
| FMR LLC | 13G | 6.20%3.78M shares | New | Aug 6, 20261 filing | Aug 6, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 5.70%3.47M shares | – | Oct 22, 20243 filings | Apr 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
53 Schedule 13D and 13G filings on Mirum Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 202612:47 PM ET | Janus Henderson Group PLC | 13G/A | 9.70%5.91M shares | −2.10 ppfrom 11.80% | Jun 30, 2026 | SEC |
| Aug 6, 202610:33 AM ET | FMR LLCand 1 other | 13G | 6.20%3.78M shares | New | Jun 30, 2026 | SEC |
| Apr 27, 20264:12 PM ET | BlackRock, Inc. | 13G/A | 5.70%3.47M shares | – | Mar 31, 2026 | SEC |
| Mar 27, 202610:52 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20264:33 PM ET | Janus Henderson Group PLC | 13G/A | 11.80%6.07M shares | +1.20 ppfrom 10.60% | Dec 31, 2025 | SEC |
| Feb 13, 20261:09 PM ET | Eventide Asset Management, LLCand 2 others | 13G/A | 4.10%2.09M shares | −1.33 ppfrom 5.43%Below 5% | Dec 31, 2025 | SEC |
| Jan 27, 20264:12 PM ET | Frazier Life Sciences IX, L.P.and 16 others | 13D/A | 6.80%4.11M shares | −0.80 ppfrom 7.60% | Jan 23, 2026 | SEC |
| Dec 5, 202512:46 PM ET | Janus Henderson Group PLC | 13G/A | 10.60%5.45M shares | +0.60 ppfrom 10.00% | Nov 28, 2025 | SEC |
| Nov 14, 20254:14 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 3.00%1.50M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 202512:03 PM ET | Janus Henderson Group PLC | 13G/A | 10.00%5.00M shares | −0.60 ppfrom 10.60% | Sep 30, 2025 | SEC |
| Nov 4, 20255:26 PM ET | Frazier Life Sciences IX, L.P.and 13 others | 13D/A | 7.60%3.74M shares | 0.00 ppfrom 7.60% | Nov 1, 2025 | SEC |
| Aug 20, 20255:17 PM ET | Frazier Life Sciences IX, L.P.and 19 others | 13D/A | 7.60%3.74M shares | – | Aug 18, 2025 | SEC |
| Aug 14, 202511:15 AM ET | Janus Henderson Group PLC | 13G/A | 10.60%5.24M shares | +0.30 ppfrom 10.30% | Jun 30, 2025 | SEC |
| Jun 6, 202511:59 AM ET | Janus Henderson Group PLC | 13G/A | 10.30%5.08M shares | +0.60 ppfrom 9.70% | May 30, 2025 | SEC |
| May 15, 20253:32 PM ET | Janus Henderson Group PLC | 13G/A | 9.70%4.78M shares | −0.40 ppfrom 10.10% | Mar 31, 2025 | SEC |
| May 14, 202511:59 AM ET | Janus Henderson Group PLCand 1 other | 13G/A | 14.30%22.7M shares | +3.30 ppfrom 11.00% | Mar 31, 2025 | SEC |
| May 7, 202510:57 AM ET | Janus Henderson Group PLC | 13G/A | 10.10%5.00M shares | +0.60 ppfrom 9.50% | Apr 30, 2025 | SEC |
| Feb 14, 202512:11 PM ET | Janus Henderson Group PLC | 13G/A | 9.50%4.58M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202512:09 PM ET | Janus Henderson Group PLCand 1 other | 13G/A | 11.00%17.1M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202512:06 PM ET | Eventide Asset Management, LLCand 2 others | 13G/A | 5.43%2.61M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202512:01 PM ET | Eventide Asset Management, LLCand 2 others | 13G/A | 3.46%2.22M shares | –Below 5% | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Eventide Asset Management, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Jul 10, 2024 | Janus Henderson Group PLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Eventide Asset Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Jan 31, 20242:08 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Dec 29, 2023 | New Enterprise Associates 16, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 18, 2023 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Sep 5, 2023 | Frazier Life Sciences IX, L.P. | 13D/AOld format | – | – | – | SEC |
| Jun 23, 2023 | New Enterprise Associates 16, L.P. | 13D/AOld format | – | – | – | SEC |
| May 3, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Apr 14, 2023 | Frazier Life Sciences IX, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 8, 20232:15 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Eventide Asset Management, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20234:27 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Dec 1, 2022 | RiverVest Venture Fund IV, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 12, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Aug 18, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Aug 16, 2022 | Frazier Life Sciences IX, L.P. | 13D/AOld format | – | – | – | SEC |
| Aug 2, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Apr 8, 2022 | Novo Holdings A/S | 13D/AOld format | – | – | – | SEC |
| Feb 15, 2022 | Rock Springs Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Oct 25, 2021 | Takeda Pharmaceutical Co Ltd | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
58 notices from officers, directors and other affiliates planning to sell Mirum Pharmaceuticals, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 20268:34 AM ET | Laura BregeDirector | 14.2K | $1.33M | Nov 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 4, 20268:41 PM ET | Joanne QuanFormer officer | 14.7K | $1.42M | Nov 4, 2026 | Morgan Stanley Smith Barney LLC | SEC |
| Nov 4, 20264:26 PM ET | Christopher PeetzOfficer · Director | 20.0K | $1.80M | Nov 4, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 15, 20264:18 PM ET | Eric BjerkholtOfficer | 9.94K | $978.1K | Sep 14, 2026 | Morgan Stanley Smith Barney LLC | SEC |
| Sep 2, 20264:06 PM ET | Jolanda Marie HoweOfficer | 658 | $65.8K | Sep 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 1, 20264:12 PM ET | Christopher PeetzOfficer · Director | 30.0K | $2.96M | Sep 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 18, 20265:24 PM ET | Jolanda Marie HoweOfficer | 40.0K | $4.00M | Aug 18, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 11, 20264:11 PM ET | Eric BjerkholtOfficer | 6.00K | $599.5K | Aug 11, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 10, 20264:17 PM ET | Christopher PeetzOfficer · Director | 20.0K | $1.98M | Aug 10, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 3, 20264:07 PM ET | Jolanda Marie HoweOfficer | 1.84K | $193.7K | Aug 3, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 6, 20264:10 PM ET | Christopher PeetzOfficer · Director | 20.0K | $2.45M | Jul 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 6, 20264:09 PM ET | Eric BjerkholtOfficer | 5.00K | $611.3K | Jul 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 1, 20265:24 PM ET | Jolanda Marie HoweOfficer | 2.72K | $326.5K | Jul 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 17, 20264:01 PM ET | Jolanda Marie HoweOfficer | 2.59K | $264.5K | Jun 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 8, 20264:20 PM ET | Eric BjerkholtOfficer | 5.00K | $469.1K | Jun 8, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 1, 20265:33 PM ET | Christopher PeetzOfficer · Director | 30.0K | $2.88M | Jun 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 1, 20264:04 PM ET | Saira RamasastryDirector | 3.98K | $397.7K | Jun 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 15, 20264:07 PM ET | Saira RamasastryDirector | 2.00K | $218.9K | May 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 15, 20264:11 PM ET | Saira RamasastryDirector | 2.00K | $193.8K | Apr 15, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 17, 20267:03 PM ET | Eric BjerkholtOfficer | 7.29K | $675.1K | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Mar 17, 20267:00 PM ET | Joanne QuanOfficer | 7.29K | $675.1K | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Mar 17, 20266:58 PM ET | Peter RadovichOfficer | 16.5K | $1.53M | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Mar 17, 20266:55 PM ET | Jolanda HoweOfficer | 4.73K | $438.4K | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Mar 17, 20266:50 PM ET | Christopher PeetzOfficer · Director | 41.0K | $3.80M | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC | SEC |
| Mar 16, 20264:04 PM ET | Saira RamasastryDirector | 2.00K | $181.5K | Mar 16, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the MIRM notices from the last 12 months